MS Trial Screen

Are you interested in participating in an MS clinical trial?

To register your interest and determine whether you may be eligible to participate in one or more of the Australian MS Clinical Trial Platform (AMSCTP) trials, you are invited to complete an eligibility survey within MS Trial Screen.

Features of MS Trial Screen:

  • Identifies which trials you meet the initial eligibility criteria for.
  • If you are eligible for multiple trials, you can choose which trial to register your interest in.
  • If you are not eligible for any current trials, you can be notified when other trials become available.
  • You can opt-out at any time.

MS Trial Screen currently supports three AMSCTP clinical trials – PLATYPUS, STOP-MS and FIRMS EBV. To read more about these trials, please scroll down. To access MS Trial screen and complete the eligibly survey now

PLATYPUS

Progressive MS

PLATYPUS is the Australian extension of an international trial called OCTOPUS. It is the first ever multi-arm, multi-stage trial for progressive MS.

STOP-MS

Progressive MS

STOP-MS is a multi-arm, multi-stage clinical trial of anti-viral agents in the treatment of progressive MS. The trial aims to find a treatment that can slow down the progression of disability in people with primary or secondary progressive MS.

FIRMS EBV

Relapsing and remitting MS

FIRMS EBV is a Phase 3 trial testing two antiviral treatments targeting Epstein-Barr virus (EBV), a virus linked to MS, to see whether they can reduce fatigue in people with MS.

MS Trial Screen was developed and is managed by the Menzies Institute for Medical Research at the University of Tasmania and has been approved by the University of Tasmania Human Research Ethics Committee (H31237). It is funded by MS Australia to help people navigate MS clinical trials in Australia.

To access MS Trial Screen and complete the eligibility survey:

Read More

Newsletter subscription

  • This field is for validation purposes and should be left unchanged.

MS Trial Screen